DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) is a blank check company sponsored by DA32 Capital LLC, formed to pursue a business combination in the life science and technology sectors. The SPAC completed its initial public offering in 2021 and filed its annual report on Form 10-K with the SEC on March 29, 2023, reflecting its continued search for a qualifying target as of fiscal year-end 2022. DALS represents one of several life science-focused SPACs that emerged during the heightened SPAC formation cycle of 2020 and 2021. Sign up at SpacDesk for complete filing history, deal timeline, and real-time status updates on DALS and hundreds of other active SPACs.